Looking to publish in Intestinal Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginIntestinal Research is a quarterly journal focused on inflammatory bowel disease and related gastroenterology topics. It publishes review articles and original articles, has print ISSN 1598-9100 and online ISSN 2288-1956, and reports an impact factor of 3.9 in Gastroenterology & Hepatology.
Looking to publish in Intestinal Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Intestinal Research accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review
Case Report
Statement
Letter To The Editor
Brief Communication
Recent Publications
Intestinal ultrasound in the assessment of complicated Crohn’s disease: a comprehensive review
Min Kyu Kim, Sung Wook Hwang
Trends and safety of small bowel endoscopy in Crohn’s disease in Japan: a large-scale claims database analysis
Shuhei Hosomi, Yu Nishida, Tsuyoshi Yanagida, Koji Fujimoto, Rieko Nakata, Akinari Sawada, Hirotsugu Maruyama, Masaki Ominami, Yuji Nadatani, Shusei Fukunaga, Koji Otani, Yasuhiro Fujiwara
Disease characteristics, outcomes, and poor prognostic factors of perianal fistula in Korean patients with Crohn’s disease: a multicenter, retrospective observational study
Hyuk Yoon, Sang Bum Kang, Seong-Joon Koh, Chang Kyun Lee, Dongwoo Kim, Eun Soo Kim, Sung Noh Hong, Dong Hyun Kim, Jin Wook Lee, Soo Jung Park, Chang Hwan Choi, Byung Ik Jang, Eun Mi Song, Soo-Kyung Park, Youngdoe Kim, Jong Min Choi, Su Young Jung, YoungJa Lee, Sang Hyoung Park
Comments on “Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease”
Longwei Qiu, Junyi Tang, Chaochi Yue
Upadacitinib and upadacitinib-vedolizumab combination therapy for refractory pediatric-onset inflammatory bowel disease
Hirotaka Shimizu, Ichiro Takeuchi, Hiroshi Oue, Hiroaki To, Atsushi Tanioka, Rina Komorizono, Katsuhiro Arai
Frequently asked questions
How long does it take to publish?
Initial decision is normally made within 6 weeks on average of receipt of a manuscript. Revised manuscripts must be resubmitted within 8 weeks of the editorial decision. Corresponding authors must respond to manuscript editor revisions within 2 days and report proof errors within 2 days.
Reformat to Intestinal Research using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should state that the submission has not been published previously or is not under consideration elsewhere, disclose potential conflicts of interest, and include preprint posting information and the preprint link when applicable. Authors including minors or family members in the research should indicate this in the cover letter.
Reformat to Intestinal Research using Livewrite PremiumWhat are the publication costs?
Individual subscription: USD 10 per issue or USD 40 annually; institutional subscription: USD 12 per issue or USD 48 annually.
Reformat to Intestinal Research using Livewrite Premium